Cas:955998-64-8 3-Piperidinecarboxylic acid, 4-hydroxy-1-(phenylmethyl)-, methyl ester manufacturer & supplier

We serve Chemical Name:3-Piperidinecarboxylic acid, 4-hydroxy-1-(phenylmethyl)-, methyl ester CAS:955998-64-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-Piperidinecarboxylic acid, 4-hydroxy-1-(phenylmethyl)-, methyl ester

Chemical Name:3-Piperidinecarboxylic acid, 4-hydroxy-1-(phenylmethyl)-, methyl ester
CAS.NO:955998-64-8
Synonyms:Methyl 1-Benzyl-4-hydroxypiperidine-3-carboxylate
Molecular Formula:C14H19NO3
Molecular Weight:249.30600
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:376.3±42.0 °C (760 mmHg)
Density:1.184±0.06 g/cm3 (20 °C, 760 mmHg)
Index of Refraction:
PSA:49.77000
Exact Mass:249.13600
LogP:0.98030

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Methyl 1-Benzyl-4-hydroxypiperidine-3-carboxylate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 1-Benzyl-4-hydroxypiperidine-3-carboxylate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 1-Benzyl-4-hydroxypiperidine-3-carboxylate Use and application,Methyl 1-Benzyl-4-hydroxypiperidine-3-carboxylate technical grade,usp/ep/jp grade.


Related News: The license, granted by the Medicines and Healthcare Products Regulatory Agency (MHRA), allows Onyx to support API projects from pre-clinical studies to low volume commercial manufacture. 2-Pyrrolidinone, 1-methyl-3-[(octylamino)methyl]- manufacturers “This announcement reflects another important regulatory milestone in the development of this medicine,” said Roy Baynes, senior vice president and head of global clinical development, chief medical officer, Merck Research Laboratories. N-[3-chloro-4-(4-hydroxy-3-propylsulfamoyl-phenoxy)-5-methyl-phenyl]-oxamic acid ethyl ester suppliers Lonza is investing CHF 20 million in GMP laboratories and mid-scale manufacturing assets at its API manufacturing center in Nansha, China. The investment will allow Lonza to provide a smoother transition from small-scale to large-scale manufacturing for customers. 1-(5-((4-chlorophenoxy)methyl)-2-(3-chlorophenyl)-1,3,4-oxadiazol-3(2H)-yl)ethan-1-one vendor & factory.